Lehigh Bioengineer Anand Ramamurthi Elected to AIMBE College of Fellows

In a significant professional milestone, Anand Ramamurthi, the Peter C. Rossin Professor of Bioengineering and chair of the Department of Bioengineering at Lehigh University, has been inducted into the esteemed American Institute for Medical and Biological Engineering (AIMBE) College of Fellows as part of the 2026 class. This prestigious accolade recognizes Ramamurthi’s groundbreaking contributions to non-invasive tissue repair technologies and innovative transformations in bioengineering education.

Ramamurthi’s interdisciplinary research focuses on the convergence of nanomedicine and regenerative therapies aimed at repairing complex tissue damage without the need for invasive procedures. His work advances the field far beyond traditional symptom management toward enabling the body’s intrinsic ability to heal, specifically targeting the extracellular matrix (ECM) and its essential components like elastic fibers—critical for the functional elasticity of tissues such as blood vessels and pelvic organs.

Elastic fibers serve as biological rubber bands that impart recoil and stretch capabilities to various organ systems. Unfortunately, these fibers do not regenerate naturally in adults once compromised due to disease or injury. Ramamurthi’s lab at Lehigh, the Ramamurthi Lab for Matrix Engineering, specializes in developing novel biomolecular strategies to restore these vital structural components. Through bioengineered nanomaterials, they aim to mimic and catalyze the regeneration of elastic fibers, offering regenerative hope where conventional treatments fall short.

One of the hallmark projects led by Ramamurthi involves a $3.2 million collaborative initiative funded by the National Institutes of Health (NIH). This research focuses on engineering drug-delivering nanoparticles tailored as a non-surgical therapeutic avenue for pelvic organ prolapse (POP), a condition affecting millions worldwide and primarily treated through invasive surgery. The nanoparticles are designed to precisely interact with and repair ECM deficiencies, thereby potentially revolutionizing treatment paradigms for POP and related tissue injuries.

Beyond pelvic organ therapies, Ramamurthi’s research extends into the vascular realm, where his team is developing active-targeting nanomedicines engineered to selectively adhere to diseased tissues, such as those affected by aortic aneurysms. These targeted therapeutics aim to modulate pathological tissue remodeling and inhibit aneurysm progression, presenting a viable alternative to high-risk surgical interventions and expanding the therapeutic landscape of cardiovascular diseases.

The American Institute for Medical and Biological Engineering’s College of Fellows represents a distinguished cadre comprising only the top 2% of medical and biological engineers worldwide. Fellowship is awarded to those who have made extraordinary contributions in their fields, whether through pioneering research, innovative practice, or transformative educational initiatives. Ramamurthi’s admission underscores his status as a leader in bioengineering who has significantly advanced translational research at the interface of medicine and engineering.

During the induction ceremony held in Arlington, Virginia, Ramamurthi joined 175 other pioneering professionals recognized for their transformative work. The AIMBE College of Fellows draws members from over 35 countries, spanning academia, industry, clinical practice, and government institutions. Distinguished members include Nobel laureates and multiple prominent figures within the National Academies of Engineering, Medicine, and Science.

Prior to his tenure at Lehigh University beginning in 2020, Ramamurthi had an illustrious academic career, serving as a professor of biomedical engineering at the Cleveland Clinic’s Lerner Research Institute and holding a professorship in molecular medicine at Case Western Reserve University. In addition to his research achievements, he is a fellow of the American Heart Association (AHA) and chairs the AHA Cardiac Basic Sciences Innovative Research Grant Study Section, highlighting his leadership in cardiovascular biomedical innovation.

Ramamurthi emphasizes that this recognition is a testament to his laboratory’s commitment to developing translational technologies that enable the body to repair itself through nanoscale engineering, marking a major step in the evolution of regenerative medicine. His pioneering approach harnesses the potential of bioengineered nanomedicines to alter disease pathophysiology at the molecular and cellular levels rather than merely mitigating clinical symptoms.

This transformative methodology represents a paradigm shift in bioengineering, aligning with the field’s broader goal of restoring biological structure and function in situ. By focusing on the ECM, and elastic fiber regeneration particularly, Ramamurthi taps into a fundamental biomechanical component responsible for tissue resilience and longevity—attributes paramount for overcoming degenerative diseases and trauma-induced dysfunction.

Lehigh University fosters this cutting-edge research environment through the Department of Bioengineering, which under Ramamurthi’s leadership continues to push boundaries in regenerative medicine. The department’s efforts are buttressed by interdisciplinary collaborations and robust funding, enabling the design of biomaterials and nanotechnologies engineered for clinical translation and improved patient outcomes.

In highlighting his induction into AIMBE, Ramamurthi reiterates his vision for a future where nanomedicine constitutes the frontline in bioengineering therapies, thus minimizing surgical risks while maximizing repair efficacy. This vision is embodied in his lab’s active projects, which integrate molecular medicine, engineering principles, and materials science to create innovative, patient-centric solutions for tissue repair and regeneration.

In sum, Anand Ramamurthi’s election to the AIMBE College of Fellows marks a significant acknowledgment of his contributions to the field of bioengineering. His pioneering work in nanotechnology-enhanced regenerative therapies is not only opening new clinical frontiers but also setting new standards for educational innovation and global bioengineering collaboration. These advancements are poised to shape the medical landscape, offering hope for millions suffering from chronic tissue degeneration and vascular diseases worldwide.

News Publication Date: April 2024

Web References:

• Lehigh University Faculty Profile – Anand Ramamurthi
• AIMBE College of Fellows
• Lehigh University NIH Collaboration on Pelvic Organ Prolapse
• Active-targeting Nanomedicines for Aortic Aneurysms

Keywords

Bioengineering, regenerative medicine, nanomedicine, tissue engineering, extracellular matrix, elastic fibers, pelvic organ prolapse, aortic aneurysm, drug delivery nanoparticles, non-invasive tissue repair, translational research, American Institute for Medical and Biological Engineering